Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II

  • Tanja Schneider
    Pharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany.
  • Thomas Kruse
    Statens Serum Institut, 2300 Copenhagen S, Denmark.
  • Reinhard Wimmer
    Department of Biotechnology, Chemistry, and Environmental Engineering, Aalborg University, DK-9000 Aalborg, Denmark.
  • Imke Wiedemann
    Pharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany.
  • Vera Sass
    Pharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany.
  • Ulrike Pag
    Pharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany.
  • Andrea Jansen
    Pharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany.
  • Allan K. Nielsen
    Novozymes AS, DK-2880 Bagsvaerd, Denmark.
  • Per H. Mygind
    Novozymes AS, DK-2880 Bagsvaerd, Denmark.
  • Dorotea S. Raventós
    Novozymes AS, DK-2880 Bagsvaerd, Denmark.
  • Søren Neve
    Novozymes AS, DK-2880 Bagsvaerd, Denmark.
  • Birthe Ravn
    Novozymes AS, DK-2880 Bagsvaerd, Denmark.
  • Alexandre M. J. J. Bonvin
    Department of Chemistry, Faculty of Science, Utrecht University, 3584 CH Utrecht, Netherlands.
  • Leonardo De Maria
    Novozymes AS, DK-2880 Bagsvaerd, Denmark.
  • Anders S. Andersen
    Statens Serum Institut, 2300 Copenhagen S, Denmark.
  • Lora K. Gammelgaard
    Novozymes AS, DK-2880 Bagsvaerd, Denmark.
  • Hans-Georg Sahl
    Pharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany.
  • Hans-Henrik Kristensen
    Novozymes AS, DK-2880 Bagsvaerd, Denmark.

抄録

<jats:title>Defining Defensins' Mode of Action</jats:title> <jats:p> Defensins are antimicrobial host defense peptides that play a role in innate immunity. Many such peptides act by disrupting the bacterial membrane; however, <jats:bold> Schneider <jats:italic>et al.</jats:italic> </jats:bold> (p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" page="1168" related-article-type="in-this-issue" vol="328" xlink:href="10.1126/science.1185723">1168</jats:related-article> ) now show that the fungal defensin, plecstasin, targets cell wall biosynthesis. Biochemical studies identified Lipid II as the cellular target of plecstasin and the residues involved in complex formation were identified using NMR spectroscopy and computational modeling. Initial studies identified two defensins from invertebrates that also target Lipid II. Plecstasin is active against some drug-resistant Gram-positive bacteria, and its action against a validated target makes it a promising lead for further drug development. </jats:p>

収録刊行物

  • Science

    Science 328 (5982), 1168-1172, 2010-05-28

    American Association for the Advancement of Science (AAAS)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ